Dr Phil Boyle - Low Dose Naltrexone for women's health (2019 Conference) (LDN, low dose naltrexone)

This Presentation was Recorded for The LDN Research Trust 2019 Conference

Drug relieves chronic pain without the addiction risk

Futurity
17 February 2021
https://www.futurity.org/naltrexone-chronic-pain-addiction-opioids-2519…

A low dose of a drug called naltrexone is a good option for patients with orofacial and chronic pain, without the risk of addiction, researchers report.

Comments on "Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review"

Pain Physician
December 2021
https://www.painphysicianjournal.com/current/pdf?article=NzM4NA%3D%3D

In Response Comments on "Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review"

Pain Physician
December 2021
https://www.painphysicianjournal.com/current/pdf?article=NzM4NQ%3D%3D

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial

Trials
15 November 2021
https://pubmed.ncbi.nlm.nih.gov/34781989/

Deena - Canada: UCTD, Chronic HSV2/Shingles, Chronic Pain, IBS, Histamine Intolerance, Vestibular Migraine, Insomnia (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Low-dose naltrexone (LDN)—review of therapeutic utilization

Med Sci (Basel)
21 September 2018
https://pubmed.ncbi.nlm.nih.gov/30248938/

Low-Dose Naltrexone Co-Treatment in the Prevention of Opioid-Induced Hyperalgesia (Abstract)

Cureus
02 September 2021
https://pubmed.ncbi.nlm.nih.gov/34646707/